Back

Where are we now? Decision-making in LDL-C lowering and CV risk

27 August 2023 (12:45 - 13:00)
Organised by: Logo
Congress Presentation Part of: Strategies to reach LDL-C goals in patients with high or very high CV risk: what's new for inclisiran? Lipid-Lowering Agents Open Access ESC Congress 2023 European Society of Cardiology

About the speaker

Photo
Professor J Wouter Jukema

Leiden University Medical Center, Leiden (Netherlands (The))

3 More presentations in this session

Presentation thumbnail
What have we learned? Long-term safety and efficacy of inclisiran
Professor R. Wright (Rochester, US)
Slides Video
Presentation thumbnail
Where are we going? Population health and the VICTORION programme
Professor K. Ray (London, GB)
Slides Video
Presentation thumbnail
Q&A and meeting close
Professor J. Jukema (Leiden, NL) Professor K. Ray (London, GB) Professor R. Wright (Rochester, US)
Slides Video

Access the full session

Session thumbnail
Strategies to reach LDL-C goals in patients with high or very high CV risk: what's new for inclisiran?
Video

The Event

Event poster

ESC Congress 2023

27 August 2023 12:45 CET
You may be interested in
thumbnail
Webinar
Update of the 2019 ESC Guidelines on Management of Dyslipidaemia: new recommendations and their impact on clinical practice
thumbnail
Webinar
Unmet needs in lipid management: treatment goals and how to achieve them
thumbnail
Congress Session
Optimising cholesterol levels through dietary interventions: key strategies and evidence

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources